This alert links to all of the Funding Opportunity Announcements and Notices published by the National Institute on Aging at NIH in the previous month, giving researchers and trainees a heads up about what’s new. Read about the latest NIA Funding Opportunities and Notices (published in August 2020) by clicking on the links below: RFA-AG-21-020: […]
NIA Funding Opportunities Read More »
Peter Davies, PhD. (1948 – 2020) It is not the most distinguished achievements that men’s virtues or vices may be best discovered; but very often an action of small note. A casual remark or joke shall distinguish a person’s real character more than the greatest sieges, or the most important battles. – Plutarch Dr. Davies
Peter Davies, Ph.D. Read More »
Need Help Applying for SBIR or STTR Funding? Preparing your first Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) application can be daunting and time-consuming. Wouldn’t it be helpful to have an experienced mentor to walk you through the process and help you refine and perfect your submission? The National Institute on Aging (NIA) Office
Need Help Applying for SBIR or STTR Funding? Read More »
New grants are available for research that begins in 2021, with an application deadline of November 10, 2020. BrightFocus is open to funding research topics related to understanding and/or intervening with biological mechanisms of Alzheimer’s disease and related dementias. The organization’s scientific portfolio includes support for innovative research ideas from scientists in the early stages of their
BrightFocus Funding Opportunity Read More »
Mark T. W. Ebbert, PhD Linkedin Twitter Google Mark Ebbert, Ph.D., studies neurodegenerative diseases using cutting-edge sequencing technologies and computational approaches such as computational biology and bioinformatics. Dr. Ebbert’s research focuses primarily on Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease). Ultimately, Dr. Ebbert aims to discover disease etiology and develop
Susanne Wegmann, PhD Linkedin Google Proteins are the ‘work horses’ of cells and enable almost all cellular functions, from genome organization over signaling cascades up to the mechanical support of cellular structures and transport of molecules. Neurons are especially polarized non-dividing cells with extreme extensions and diverse microenvironments, which asks for robustly regulated and highly
Albert (Gus) Davis, MD, PhD Twitter I am a neurologist and neuroscientist with interests in neurodegenerative diseases, protein aggregation, and mechanisms underlying neuron injury and death. My long term goal is to better understand the molecular events that influence the pathological aggregation of disease-associated proteins contributing to dementia in Alzheimer disease (AD) and Parkinson disease
Zvinka Zlatar, PhD Linkedin Google Dr. Zlatar received her PhD in clinical psychology from the University of Florida, with a focus on adult neuropsychology/geropsychology. She completed her APA-accredited clinical psychology internship at the University of California, Los Angeles (Semel Institute for Neuroscience and Human Behavior), focusing on the neuropsychological assessment of older adults and Spanish-speaking
Cristian Lasagna-Reeves, PhD Linkedin Twitter Facebook Google My scientific career has revolved around the study of protein aggregation in neurodegenerative diseases. To investigate the mechanism of these diseases, I have used a broad range of strategies, such as in Vitro aggregation assays with recombinant protein, disease cellular models, mouse genetic interaction experiments, behavioral studies, and
Cristian Lasagna-Reeves Read More »
Robert Hill, PhD Linkedin Twitter Google The Hill lab at Dartmouth uses high-resolution optical imaging approaches to investigate how diverse cell populations dynamically interact in the brain. We develop and implement new techniques that allow visualization and manipulation of these distinct cell types in their native environment. For the 2017 Charleston Conference on Alzheimer’s Disease
